Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CeraVe Psoriasis Moisturizing Cream** is a human over-the-counter topical salicylic acid cream for relief of itching, scaling, redness, flaking, irritation, and dry skin associated with psoriasis, and for helping prevent recurrence of psoriasis symptoms. Its sole drug active is salicylic acid 2%, a small-molecule keratolytic that promotes exfoliation and reduces surface scale. The cream also includes moisturizing and skin-barrier-supporting inactive ingredients such as urea, niacinamide, shea butter, and ceramides, and uses CeraVe MVE technology to release moisturizing ingredients over time. ([cerave.com](https://www.cerave.com/skincare/moisturizers/psoriasis-moisturizing-cream))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CeraVe Psoriasis Moisturizing Cream.